ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS
© 2023 The Authors. Published under the terms of the CC BY 4.0 license..
Most SARS-CoV-2 proteins are translated from subgenomic RNAs (sgRNAs). While the majority of these sgRNAs are monocistronic, some viral mRNAs encode more than one protein. One example is the ORF3a sgRNA that also encodes ORF3c, an enigmatic 41-amino-acid peptide. Here, we show that ORF3c is expressed in SARS-CoV-2-infected cells and suppresses RIG-I- and MDA5-mediated IFN-β induction. ORF3c interacts with the signaling adaptor MAVS, induces its C-terminal cleavage, and inhibits the interaction of RIG-I with MAVS. The immunosuppressive activity of ORF3c is conserved among members of the subgenus sarbecovirus, including SARS-CoV and coronaviruses isolated from bats. Notably, however, the SARS-CoV-2 delta and kappa variants harbor premature stop codons in ORF3c, demonstrating that this reading frame is not essential for efficient viral replication in vivo and is likely compensated by other viral proteins. In agreement with this, disruption of ORF3c does not significantly affect SARS-CoV-2 replication in CaCo-2, CaLu-3, or Rhinolophus alcyone cells. In summary, we here identify ORF3c as an immune evasion factor of SARS-CoV-2 that suppresses innate sensing in infected cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
EMBO reports - 24(2023), 12 vom: 06. Dez., Seite e57137 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Müller, Martin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cryptic open reading frames |
---|
Anmerkungen: |
Date Completed 11.12.2023 Date Revised 11.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.15252/embr.202357137 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363626077 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363626077 | ||
003 | DE-627 | ||
005 | 20231227131816.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.15252/embr.202357137 |2 doi | |
028 | 5 | 2 | |a pubmed24n1226.xml |
035 | |a (DE-627)NLM363626077 | ||
035 | |a (NLM)37870297 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Müller, Martin |e verfasserin |4 aut | |
245 | 1 | 0 | |a ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.12.2023 | ||
500 | |a Date Revised 11.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Published under the terms of the CC BY 4.0 license. | ||
520 | |a Most SARS-CoV-2 proteins are translated from subgenomic RNAs (sgRNAs). While the majority of these sgRNAs are monocistronic, some viral mRNAs encode more than one protein. One example is the ORF3a sgRNA that also encodes ORF3c, an enigmatic 41-amino-acid peptide. Here, we show that ORF3c is expressed in SARS-CoV-2-infected cells and suppresses RIG-I- and MDA5-mediated IFN-β induction. ORF3c interacts with the signaling adaptor MAVS, induces its C-terminal cleavage, and inhibits the interaction of RIG-I with MAVS. The immunosuppressive activity of ORF3c is conserved among members of the subgenus sarbecovirus, including SARS-CoV and coronaviruses isolated from bats. Notably, however, the SARS-CoV-2 delta and kappa variants harbor premature stop codons in ORF3c, demonstrating that this reading frame is not essential for efficient viral replication in vivo and is likely compensated by other viral proteins. In agreement with this, disruption of ORF3c does not significantly affect SARS-CoV-2 replication in CaCo-2, CaLu-3, or Rhinolophus alcyone cells. In summary, we here identify ORF3c as an immune evasion factor of SARS-CoV-2 that suppresses innate sensing in infected cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a IFN antagonist | |
650 | 4 | |a ORF3c | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a cryptic open reading frames | |
650 | 4 | |a immune evasion | |
650 | 7 | |a DEAD Box Protein 58 |2 NLM | |
650 | 7 | |a EC 3.6.4.13 |2 NLM | |
700 | 1 | |a Herrmann, Alexandra |e verfasserin |4 aut | |
700 | 1 | |a Fujita, Shigeru |e verfasserin |4 aut | |
700 | 1 | |a Uriu, Keiya |e verfasserin |4 aut | |
700 | 1 | |a Kruth, Carolin |e verfasserin |4 aut | |
700 | 1 | |a Strange, Adam |e verfasserin |4 aut | |
700 | 1 | |a Kolberg, Jan E |e verfasserin |4 aut | |
700 | 1 | |a Schneider, Markus |e verfasserin |4 aut | |
700 | 1 | |a Ito, Jumpei |e verfasserin |4 aut | |
700 | 1 | |a Müller, Marcel A |e verfasserin |4 aut | |
700 | 1 | |a Drosten, Christian |e verfasserin |4 aut | |
700 | 1 | |a Ensser, Armin |e verfasserin |4 aut | |
700 | 0 | |a Genotype to Phenotype Japan (G2P-Japan) Consortium |e verfasserin |4 aut | |
700 | 1 | |a Sato, Kei |e verfasserin |4 aut | |
700 | 1 | |a Sauter, Daniel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t EMBO reports |d 2000 |g 24(2023), 12 vom: 06. Dez., Seite e57137 |w (DE-627)NLM111633540 |x 1469-3178 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:12 |g day:06 |g month:12 |g pages:e57137 |
856 | 4 | 0 | |u http://dx.doi.org/10.15252/embr.202357137 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 12 |b 06 |c 12 |h e57137 |